Reflections on the prevention and control of COVID-19 and future global pandemics

Clinical and immunological features of COVID-19 : Implications for management

Severe acute non-A-E hepatitis in Children in 2021-2022 and managing a global response

Global COVID-19 epidemic trend and the construction of China's public health system

Safety and immunogenicity of COVID-19 vaccination in patients with liver diseases

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019

MRI evaluation of COVID-19 related brain injury MRI evaluation of COVID-19 related brain injury

Panel Discussion

Clinical characteristics and prognosis of concomitant autoimmune hepatitis and nonalcoholic fatty liver disease

Human umbilical cord blood mononuclear cells ameliorate CCl4-induced acute liver injury in mice via inhibiting inflammatory responses and up-regulating peripheral interleukin-22

CMTM4 promotes the proliferation and metastasis of hepatocellular carcinoma through the regulation of AKT and PD-L1

Soluble Fibrinogen-Like Protein 2 Promotes the Progression of Hepatocellular Carcinoma by Inducing the Expression of Immune Checkpoints

Small extracellular vesicles derived from induced pluripotent stem cells to alleviate lipopolysaccharide /D-galactosamine induced acute liver failure

Significant serum proteinic and metabolic alterations in hepatitis B cirrhosis patients treated with umbilical cord mesenchymal stem cells

Clinical value of highly sensitive detection in CHB LLV patients

Novel biomarkers for the management of chronic hepatitis B

Definition of HBV cure and treatment endpoint

Basic biology of HBV: glance over cccDNA transcription

Quantitative anti-HBc but not HBcrAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients

Panel Discussion

24-week combination treatment of TLR7 agonist TQ-A3334 and PD-L1 inhibitor TQ-B2450 enhanced HBsAg reduction in NAs-suppressed CHB patients: a preliminary analysis of a phase II study (OCEANcure05)

Immunogenicity of Inactivated COVID-19 Vaccines in Chronic Hepatitis B Patients with Antiviral Therapy

Lipid nanoparticle-mediated delivery of mRNA vaccine for IL-21 achieves clearance of hepatitis B virus (HBV) persistence in mouse models

Subcutaneous PD-L1 Antibody ASC22 (Envafolimab) plus Nucleos(t)ide Analogs Achieved Functional Cure of Chronic Hepatitis B in 42.9% of Patients with HBsAg ≤100 IU/mL: Interim Results from a Phase IIb Clinical Trial

Clinical evaluation of metagenomic next-generation sequencing method for the diagnosis of suspected ascitic infection in patients with liver cirrhosis in a clinical laboratory

Metabolic Factors and Steatosis Increase the Risk of Adverse Outcomes in Treatment-Naïve Chronic Hepatitis B Patients with Normal Alanine Aminotransferase

High rates of HBV functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy

Prognosis era 2.0 for HBV-ACLF

Hepatic encephalopathy

Management of acute hepatic failure

Management of end-stage liver disease complicated with infections

Panel Discussion

Myeloid cells in alcohol related liver injury

Research progress of non coding RNA in reversing liver fibrosis

Acute-on-chronic liver failure (ACLF) and regeneration

Immune-pathological mechanisms and potential therapies of liver diseases

Methylation biomarkers in acute-on-chronic hepatitis B liver failure

Type-specific functions and related mechanisms of IFN-α against Hepatitis B Virus

Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating EFTUD2

Sofosbuvir-based therapy for late pregnant women and infant with severe chronic hepatitis C

Liver failure due to HBV reactivation

Liver failure：what we are doing and what we can do？

Antiviral therapy in EBV infection

Explore the new etiology of childhood inherited cholestasis

Landscape of Pediatric Liver Transplantation in Mainland China

How to diagnose primary immunodeficiency disease earlier？

Plasma exchange and pediatric acute liver failure

Management of children after liver transplantation

Sepsis induced liver injury

Hepatology in Asia: 50 years and the future

Update on IgG4-related cholangitis (IRC)

CCIFLDI meets APASL: A history of first golden ten years

How to achieve WHO goal of HBV control?

Clinical utility of new viral biomarkers for CHB

Stopping rules of NA therapy

Severe HBV flare with acute-on-chronic liver failure

Panel Discussion

Difference between type 2 gastroesophageal varices and isolated fundic varices in clinical profiles and portosystemic collaterals

A low albumin to globulin ratio is a prognostic marker for bacterial infection in alcohol-related liver cirrhosis: a retrospective study

Clinical evaluation of bacterial DNA using an improved droplet digital PCR for the diagnosis of spontaneous bacterial peritonitis

Research on Factors Linked with Occurrence of Minimal/Covert Hepatic Encephalopathy and Development of Overt Hepatic Encephalopathy

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Albumin in Cirrhotic Patients with Ascites

Mechanism-of-Action for Exosomes Derived from Human Adipose Mesenchymal Stem Cells in Liver Cirrhosis Treatment

New pattern and new challenges, update of optimal strategies for chronic hepatitis B

Clinical Cure Advances of Non-Active Hepatitis B's Antigen Carries (IHCs)

Management of acute and fulminant hepatitis B

A novel, long acting, interferon (Ropeginterferon) for chronic viral hepatitis B or D

HBV and MAFLD: intriguing interactions

Extension of treatment criteria in HBV

Panel Discussion

Bacterial infections in patients with cirrhosis

Regulatory innate immune response in hepatitis B infection

New treatment in management of chronic viral hepatitis B

HBV Cure Strategy

Functional cure strategy

Distribution and progress of liver diseases

Panel Discussion

Advantages of DPMAS in the treatment of HBV-ACLF

Breakthrough、Innovation、Insight

Use and abuse of albumin in management of critically ill patients with cirrhosis

Management of refractory ascites

Decompensation and recompensation: management of ascites

Role of vasoconstrictor in management of refractory ascites and related complications in cirrhosis

Panel Discussion

Mechanism of MIF promoting inflammatory polarization of liver macrophages mediating acute liver failure

Defection of GLT25D1 Exacerbated Con A Induced Liver Injury by Promoting Polarization of M1-type Macrophage via MAPK Signaling Pathway

Observation on short-term effect of sequentially combined multi-modal artificial liver treatment on HBV-related acute-on-chronic liver failure

G protein-coupled receptor-35 alleviates non-alcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes

Etiology and prognostic criteria of liver failure in southeast China: A multicenter retrospective cohort study between 2018 and 2020

Enoxaparin attenuates monocrotaline-induced hepatic sinusoidal obstruction syndrome by inhibiting hepatocellular oncostatin M expression

FGL2-MCOLN3-autophagy axis-triggered neutrophil extracellular traps exacerbate liver injury in fulminant viral hepatitis

Algorithm and Choice of Antibiotics in ACLF

Infections in cirrhosis and critical care

Bacterial infections in ESLD

Clinical insight into the involvement of gut and liver to spontaneous bactrial peritonitis in hepatic cirrhosis

Panel Discussion

Diagnosis and management of idiopathic noncirrhotic portal hypertension

Diagnosis and management of portal hypertension

Chronic Portal vein thrombosis management

Hepatitis B virus persistence and reactivation related ACLF

Panel Discussion

Brain complications in critical care in cirrhosis

A Quick and Early Diagnostic Model for Minimal Hepatic Encephalopathy in ESLD

Hepatic encephalopathy: Japanese Guideline 2020 and role of microbiome

Neurodegeneration in liver disease

Panel Discussion

AKI and HRS

Hepatorenal syndrome

Diagnosis and Management of AKI-HRS

Optimal use of terlipressin in the treatment of hepatorenal syndrome

Panel Discussion

Treating hypo and hyper coagulation the current advances

Hematological issues in liver disease

Coagulopathy in severe viral infection

Management of portal vein thrombosis

Panel Discussion

Dynamic bioenergetics of sepsis in ACLF

Mesenchymal Stem Cell Therapy for ACLF and DLC Patients

Recent advances and pharmacological treatments in severe alcohol associated hepatitis

Inflammation in NASH: regulators and therapeutic targets

Diagnosis and assessment of cirrhosis in non-alcoholic fatty liver disease

Leveraging fatty acid oxidation in skeletal muscle for the management of non-alcoholic fatty liver disease

Prevalence and impact of co-existing NAFLD in patients with HBV infection

Panel Discussion

Soluble ST2 Serum Concentration Predicts Efficacy of Artificial liver support system in Acute-on-chronic liver failure.

Upregulation of microRNA-125b-5p alleviates acute liver failure through regulating Keap1/Nrf2/HO-1 pathway

Decreased vitamin D-binding protein level portends poor outcome in acute-on-chronic liver failure caused by hepatitis B virus

Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in acute-on-chronic liver failure by inhibiting pyroptosis but not necroptosis signalling

Contrast-free ultrasensitive ultrasound imaging for in-vivo quantitative evaluation of hepatic microcirculation in cirrhotic rats

Monocyte subsets predicts outcome of hepatitis B virus related Acute-on-Chronic Liver Failure patients

Prediction of prognosis of hepatitis B virus-related acute-on-chronic liver failure by LEAP-HBV model based on whole liver volume

Viral infection, inflammation and lipid metabolism

From NAFLD to MAFLD

MAFLD and liver cancer

MAFLD and extrahepatic manifestation

Panel Discussion

Biotherapy for liver diseases

Optimal management in the era of evolution of the treatment for HCC

Ex-vivo Liver Resection and Autotransplantation(ELRA): benign (parasitic) tumors

Evidence to support changing the treatment thresholds in CHB

Boosting viral-specific immune therapy by mimogen for cure of chronic hepatitis B

Liver injury in patients with COVID-19

Pay more attention to HEV and HBV superinfection clinically

Panel Discussion

Management of cirrhotic complications such as AKI, Variceal hemorrahge

TIPS for the management of acute variceal bleeding

High risk varcies screening and surveillance in liver cirrhosis

Non-invasive and invasive tests of Hepatic Venous Pressure for cirrhotic patients with risk of gastrointestinal bleeding

Panel Discussion

A novel prognostic nomogram for older patients with acute-on-chronic liver diseases (AoCLD): a nationwide, multicenter, prospective cohort study

Establishment and validation of a quick bedside test with number connection test A and animal and vegetable naming test for minimal hepatic encephalopathy

Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NFκB pathways

Single-Cell Profiling Reveals the Metastasis-Associated Immune Signature of Hepatocellular Carcinoma

microRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression

A Chinese system of staging and treatment strategy for post-hepatectomy recurrent hepatocellular carcinoma

Presence of liver inflammation and fibrosis in Asian patients with chronic hepatitis B in the grey zone

HBV capsid assembly modulators in the functional cure of CHB

HBV cure: immunological mechanisms

Hyperdynamic circulation in cirrhosis

Revisit the natural history of chronic HBV infection

Panel Discussion

Hypoxic hepatitis update

The pathogenesis of primary biliary cholangitis

Acute presentation of AIH - how to find and manage

Multi-organ injury in the metabolic syndrome

Panel Discussion

Acute HBV related liver failure

Role of nutrition in critical care

Diagnosis and treatment of end-stage liver disease combined with severe infection

Management of ACLF in the context of liver transplantation

Panel Discussion

Algorithms for managing MDR infections in liver ICU

Mesenchymal stem cells therapies for Covid-19: from bench to bedside

Progress in diagnosis and treatment of sepsis-related cholestatic liver disease

ACLF and organ support

Panel Discussion

HCC: Who to transplant?

Biliary complications due to living donor liver transplantation

HCC risk and surveillance in patients with cirrhosis

Prevention of HBV-related HCC through antiviral treatment

Panel Discussion